CSIRO Publishing blank image blank image blank image blank imageBooksblank image blank image blank image blank imageJournalsblank image blank image blank image blank imageAbout Usblank image blank image blank image blank imageShopping Cartblank image blank image blank image You are here: Journals > Reproduction, Fertility and Development   
Reproduction, Fertility and Development
Journal Banner
  Vertebrate reproductive science and technology
blank image Search
blank image blank image
blank image
  Advanced Search

Journal Home
About the Journal
Editorial Structure
Online Early
Current Issue
Just Accepted
All Issues
Special Issues
Research Fronts
Virtual Issues
Sample Issue
For Authors
General Information
Submit Article
Author Instructions
Open Access
Awards and Prizes
For Referees
Referee Guidelines
Review an Article
Annual Referee Index
For Subscribers
Subscription Prices
Customer Service
Print Publication Dates
Library Recommendation

blue arrow e-Alerts
blank image
Subscribe to our email Early Alert or RSS feeds for the latest journal papers.

red arrow Connect with us
blank image
facebook twitter logo LinkedIn

red arrow Connect with SRB
blank image
facebook TwitterIcon

Affiliated Societies

RFD is the official journal of the International Embryo Transfer Society and the Society for Reproductive Biology.


Article << Previous     |     Next >>   Contents Vol 4(4)

Identification of molecules and mechanisms involved in the 'early pregnancy factor' system

FM Clarke

Reproduction, Fertility and Development 4(4) 423 - 433
Published: 1992


For a long time the 'early pregnancy factor' has defied molecular definition. First described in 1976, this phenomenon is revealed in vitro by the rosette inhibition assay, in which a lymphocyte-modifying activity in maternal serum is detected within hours of fertilization; it is present for at least the first two-thirds of pregnancy, with continued detection dependent upon the presence of a viable embryo or fetus. It has potential applications in early pregnancy testing, for monitoring fetal well-being and in the study of fertility control. Although the activity detected is one of a complex biological fluid (pregnancy serum) in a complex biological assay, this ability of pregnancy sera to cause increased rosette inhibition titres (RIT) has generally been ascribed to the presence of an 'early pregnancy factor' (EPF). The common usage of the term EPF has implied the existence in pregnancy sera of a unique factor, which has often been assumed to be a novel, pregnancy-specific protein with the unique capacity to induce increased RITs. Recent results render this concept untenable. These studies have begun to identify the molecules and mechanisms which cause the expression of increased RITs. In particular, thioredoxin or thioredoxin-like molecules have been identified as involved in the mechanisms by which pregnancy sera induced increased RITs. As a result, a new paradigm for the EPF phenomenon is presented which helps to resolve many of the enigmatic properties previously ascribed to the so-called 'early pregnancy factor' and which may assist in the further understanding of the molecular mechanisms of communication between embryo and mother prior to implantation.

Full text doi:10.1071/RD9920423

© CSIRO 1992

blank image
Subscriber Login

PDF (578 KB) $25
 Export Citation
Legal & Privacy | Contact Us | Help


© CSIRO 1996-2016